NOVARTIS HEALTHCARE A/S: Financial statements 2019
CVR: 20575786
NOVARTIS HEALTHCARE A/S (CVR 20575786) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 966,610,602 and a net result of DKK -98,557,563 compared with DKK 83,223,234 the year before. That is an increase of 11.4% compared with the year before. The profit margin was -10.2%. Equity amounted to DKK 21,166,566. The solvency ratio was 2.8%. The company had 126 employees in the financial year.
- Revenue
- 966,610,602 kr.
- Gross Profit
- 170,585,544 kr.
- Profit/Loss
- -98,557,563 kr.
- Equity
- 21,166,566 kr.
- Total Assets
- 748,522,613 kr.
- Employees
- 126
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 966.6 mio. | 170.6 mio. | -98.6 mio. | 21.2 mio. | 126 |
| 2018 | 867.8 mio. | 168.9 mio. | 83.2 mio. | 119.7 mio. | 107 |
| 2017 | 731.8 mio. | 188 mio. | 29.4 mio. | 186.5 mio. | 113 |
| 2016 | 677.9 mio. | 143.8 mio. | 35.4 mio. | 307.1 mio. | 136 |
| 2015 | 624.2 mio. | 151.3 mio. | 11 mio. | 271.6 mio. | 134 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
NOVARTIS HEALTHCARE A/S has published its annual report for 2018. Revenue came to DKK 867,835,367, and the net result was DKK 83,223,234.
As of May 10, 2019, Judith Louise Love has joined the board of directors of NOVARTIS HEALTHCARE A/S.
As of May 10, 2019, Niklas Olof Karlberg has left the board of directors of NOVARTIS HEALTHCARE A/S.
As of May 10, 2019, Judith Louise Love is registered as adm. dir. of NOVARTIS HEALTHCARE A/S.
As of May 10, 2019, Niklas Olof Karlberg has stepped down as adm. dir. of NOVARTIS HEALTHCARE A/S.
About NOVARTIS HEALTHCARE A/S
NOVARTIS HEALTHCARE A/S is a Danish company of the type Aktieselskab based in København S, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Peter Drøidal. The company is owned by Novartis Pharma AG. The company has 125 employees.
